Therefore, as the level of endogenous BID[18], functioning of TRAIL-induced signaling[23], and activity of CK2[24] differ in particular cancer cells, some cells may be expected not to respond on elevation of cellular concentration of BID whereas other ones may be sensitized by BID. This evidence concerns the gene BID and cancer.